Idiopathic epilepsy (also termed primary generalized epilepsy) occurs in people possessing no evident abnormalities in the structural architecture of the brain and is presumptively genetic in its ...

Recent research presented at the American Epilepsy Society Annual Meeting examined the relationship between misinformation ...

Patients with treatment-resistant epilepsy often cycle through multiple medications as they seek relief from the seizures that disrupt their lives. Yet in many cases, these drugs offer little benefit, ...

The Epilepsy Foundation of America (EFA) is featured in a special three-episode podcast series created to inform, inspire, and connect individuals, families, caregivers, and advocates impacted by ...

Lamotrigine, sold under the brand name Lamictal, represents about 10% of all antiseizure medication use. In 2020, the FDA placed a safety warning label on lamotrigine based on reports that the drug ...

A new study published in The Journal of Pediatrics finds no evidence linking routine childhood vaccinations or aluminium ...

Purple Day, observed annually on March 26, raises epilepsy awareness and dispels myths. Despite affecting 50 million people worldwide (WHO, 2022), epilepsy remains misunderstood, leading to stigma and ...

The parents of a seven-year-old epileptic boy taking on the Forth Road Bridge challenge next month are “immensely proud” of ...

Researchers at Rutgers University-New Brunswick (N.J.) are questioning the FDA’s 2020 decision to place a safety warning on a common antiseizure medication. Lamictal (lamotrigine), a GSK medicine ...